Anticancer effects of Erzhimaoling decoction in high-grade serous ovarian cancer in vitro and in vivo
EZMLD has therapeutic potential for ovarian cancer and may be considered for other cancer types. Future research may explore its broader effects beyond cell apoptosis.
Authors
- Feng Shao
- Jiejie Zhang (ORCID: https://orcid.org/0000-0001-8114-1988)
- Yang Li (ORCID: https://orcid.org/0000-0002-9725-8774)
- Jie Xing (ORCID: https://orcid.org/0000-0002-5689-9268)
- Yanlu Jin
- Aijun Yu (ORCID: https://orcid.org/0000-0002-9212-0362)
- Heran Zhou (ORCID: https://orcid.org/0009-0002-2519-2654)
- Jingfang Liu (ORCID: https://orcid.org/0000-0003-1908-4454)
Institutions
- Zhejiang Chinese Medical University (CN)
- Zhejiang Cancer Hospital (CN)
Publication Details
- Journal
- European journal of medical research
- Published
- 2024-08-05
- DOI
- https://doi.org/10.1186/s40001-024-01968-4
- Citations
- 1
- Primary Topic
- Ovarian cancer diagnosis and treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.54
Funders
- National Natural Science Foundation of China
- Chinese Medicine Research Program of Zhejiang Province